FDA Clearance Tracker · P160001-S047
Obalon Balloon System
Last checked: Nov 20, 2026Latest source record: Jul 18, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Jul 18, 2022
Approved
Time to decision
180 days
Received Jan 19, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P160001-S047
- Device name
- Obalon Balloon System
- Applicant
- Medtimo, Inc.
- Applicant location
- Eden Prairie, MN
- Received
- Jan 19, 2022
- Decided
- Jul 18, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P160001
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the labeling reflecting the findings of the post-approval study (PAS) protocol.
Source documents
Other decisions for Medtimo, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P160001 · Decided Sep 8, 2016 · 245 days after receipt
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.